首頁 >產品介紹>免疫實驗相關試劑耗材>試劑-小分子重組抗體>Creative Biolabs 熱門研究用小分子抗體藥
免疫實驗相關試劑耗材
| Cat. No | Product Name | Antibody | Indications |
| TAB-731 | Anti-GD2 Therapeutic Antibody | Dinutuximab | Neuroblastoma |
| TAB-114 | Anti-Human CA-125 Therapeutic Antibody | Abagovomab | Ovariancancer cancer |
| TAB-H01 | Anti-Human ITGAV Therapeutic Antibody | Abituzumab | Colorectal cancers,metastatic |
| TAB-106 | Anti-Human EPCAM Therapeutic Antibody | Adecatumumab | Prostate and breast cancer |
| TAB-133 | Anti-Human CD20 Therapeutic Antibody | Afutuzumab | Lymphoma |
| TAB-201 | Anti-Human Mesothelin Therapeutic Antibody | Amatuximab | Pancreatic cancers |
| TAB-150 | Anti-Human HLA DR beta Therapeutic Antibody | Apolizumab | Chronic lymphocytic leukemia |
| TAB-011 | Anti-Human VEGF Therapeutic Antibody | Bevacizumab | Colorectal cancers,metastatic |
| TAB-H09 | Anti-Human CD44 Therapeutic Antibody | Bivatuzumab mertansine | Squamous cell carcinoma |
| TAB-728 | Anti-CD19 Therapeutic Antibody | Blinatumomab | Acute lymphocytic leukemia |
| TAB-H11 | Anti-Human NOTCH1 Therapeutic Antibody | Brontictuzumab | Lymphoma |
| TAB-078 | Anti-Human IGF1 Receptor Therapeutic Antibody | Cixutumumab | Non-small cell lung cancers |
| TAB-H14 | Anti-Human GPC3 Therapeutic Antibody | Codrituzumab | Hepatocellular carcinoma |
| TAB-203 | Anti-Human DR5 Therapeutic Antibody | Conatumumab | Non-small cell lung cancers |
| TAB-144 | Anti-Human CD30 Therapeutic Antibody | Iratumumab | Hodgkin's lymphoma |
| TAB-764 | Anti-ganglioside GD3 Therapeutic Antibody | Mitumomab | Small cell lung carcinoma |
| TAB-H56 | Anti-Human MUC1 Therapeutic Antibody | Pemtumomab | Cancers |
| TAB-209 | Anti-Human IGF1 Receptor Therapeutic Antibody | Robatumumab | Blood cancers |
| TAB-877 | Anti-Human Tenascin C/TNC Therapeutic Antibody | Tenatumomab | Cancers |
| TAB-206 | Anti-Human CTLA4 Therapeutic Antibody | Ticilimumab | Cancers |
| TAB-005 | Anti-Human ErbB2 Therapeutic Antibody | Trastuzumab | Breast cancers |
| TAB-207 | Anti-Human CD20 Therapeutic Antibody | Ublituximab | Chronic lymphocytic leukemia |
| TAB-880 | Anti-Human Frizzled receptor Therapeutic Antibody | Vantictumab | Solid tumors |
| TAB-264 | Anti-Human NRP1 Therapeutic Antibody | Vesencumab | Solid tumors |
| TAB-715 | Anti-CTAA16.88 Therapeutic Antibody | Votumumab | Colorectal tumors |
| TAB-H35 | Anti-Human EGFR Therapeutic Antibody | Futuximab | Colorectal tumors |
| TAB-033 | Anti-Human CEACAM5 Therapeutic Antibody | Labetuzumab | Colorectal tumors |